澳大学研制新药有望用于治疗新冠引发的血管堵塞-新华网 新华社悉尼7月26日电（记者陈宇）澳大利亚莫纳什大学的研究人员正在研发一种有助于预防心脏病和中风的新药，并希望这种药物能用于治疗由新冠病毒引发的血管堵塞。 研究人员发现，在心脏病或中风发作前，血小板中的一种酶会加速血小板凝结。 由此他们研发一种药物，可以暂时性抑制血小板凝结，从而避免血管堵塞，对心脏病和中风起到预防作用。 研究人员表示，这种药物只会在出现心脏病或中风征兆时，抑制血小板的凝结效应。 由于有研究显示类似的血管堵塞是导致新冠重症患者死亡的主要原因之一，研究人员希望这种药物在将来可以用于此类重症患者的治疗。 目前，该药物已在动物模型实验中取得良好效果，研究人员准备下一阶段进行人体临床试验。 研究成果日前已发表在美国《科学·转化医学》杂志上。
A new drug developed by Australian university is expected to be used to treat vascular occlusion caused by COVID-19 - www.xinhuanet.com Xinhua News Agency, Sydney, July 26 (Reporter Yu Chen) – Researchers of Monash University of Australia are developing a new drug that can help prevent heart disease and stroke, and hope that this drug can be used to treat blood vessel blockage caused by COVID-19 Researchers have found that an enzyme in platelets can accelerate platelet coagulation before a heart attack or stroke. Therefore, they are developing a drug that can temporarily inhibit platelet coagulation, thus avoiding blood vessel blockage and preventing heart disease and stroke. Researchers said that this drug would only inhibit the clotting effect of platelets when there was a sign of heart disease or stroke. As studies have shown that similar vascular occlusion is one of the main causes of death of severe patients in COVID-19, researchers hope that this drug can be used for the treatment of such severe patients in the future. At present, this drug has achieved good results in animal model experiments, and researchers are preparing to conduct human clinical trials in the next stage. The research results have been published recently in the Science Translational Medicine, an American Journal.